Meta AnalysisID 2816

青黛制剂治疗溃疡性结肠炎疗效与安全性的系统评价

CRD42022354838

Systematic evaluation of the efficacy and safety of indigo naturalis PreParation in the treatment of ulcerative colitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2816
Evidence Id
11374
Core Evidence Id
11374
Source Meta Analysis Id
2760
Herb2 Meta Analysis Id
HBMA002760
Crd Id
CRD42022354838
Title
Systematic evaluation of the efficacy and safety of indigo naturalis PreParation in the treatment of ulcerative colitis
Review Question
Systematic evaluation of the efficacy and safety of indigo naturalis PreParation in the treatment of ulcerative colitis
Study Type Included
Randomized controlled trials (RCTs) will be included.
Condition Being Studied
Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease involving the colon and rectum, and its etiology remains unknown. The lesions are confined to the mucosa and submucosa of the large intestine. Most of the lesions are located in the sigmoid colon and rectum, but they can also extend into the descending colon or even the entire colon. The duration of UC is usually prolonged. Its clinical manifestations include persistent or recurrent diarrhea, mucopurulent bloody stool with abdominal pain, and tenesmus, of which mucopurulent bloody stool is the most common symptom. In recent years, the incidence of UC has been increasing year by year worldwide, even in developing countries where the incidence was previously low.
Participant
(1) Study type: clinical randomized controlled trial, with or without blind method and no limitation in publication language; (2) Subjects: All patients who met the diagnostic criteria for ulcerative colitis. Diagnostic criteria: TCM diagnostic criteria were mainly determined by referring to Practical Internal Medicine and Criteria for Diagnosis and Therapeutic Effect of Diseases and Syndromes in TCM. Western medicine diagnostic criteria were mainly formulated with reference to Criteria for Diagnosis and Therapeutic Effect of Ulcerative Colitis. Patients' age, course of disease and source of cases are not limited; (3) Intervention measures: treatment group was treated with indigo naturalis; The control group was treated with western medicine. (4) Outcome measures: At least one of the following measures was adopted: ① Total effective rate; ② Efficacy evaluation under colonoscopy; ③ TCM symptom scores; ④ Score of intestinal mucosal lesion; ⑤ Sutherland disease activity index (DAI) and maintenance response rate; ⑥ Recurrence rate; ⑦ Adverse reactions.
Animal
Human Disease Modelled
Intervention
The main intervention measure of the experimental group was Indigo Naturalis。
Comparator Control
The intervention method of the control group was oral administration of western medicine (mesalazine or sulfasalazine).
Main Outcome
Clinical remission rate, adverse reactions, DAI score at the fourth week
Outcome Measure
Additional Outcome
Abdominal pain, diarrhea, bloody stool score, colonoscopy score
Study Method
系统综述
Keyword
Colitis, Ulcerative; Humans; Indigo Carmine; Indigofera; Psoriasis
Contact
SHI CAI HUANG [email protected]
Organisational Affiliation
KUNSHAN INTEGRATED TCM AND WESTERN MEDICINE HOSPITAL
Funding Source
Project of Suzhou Science and Technology Bureau(subject number SYSD2019200)
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China, England
Review Stage
Review Ongoing
First Submission Date
2022-08-20
Registration Date
2022-08-31
Anticipated Start Date
2022-08-20
Anticipated Completion Date
2022-09-23
Title Cn
青黛制剂治疗溃疡性结肠炎疗效与安全性的系统评价
Title En
Systematic evaluation of the efficacy and safety of indigo naturalis PreParation in the treatment of ulcerative colitis
Bilingual Status
complete